
Investigational anti-inflammatory, OMS103HP, provides excellent results for ACLR

Investigational anti-inflammatory, OMS103HP, provides excellent results for ACLR
Novel Drug Product to Improve Joint Motion and Function and Reduce Pain After Arthroscopic Anterior Cruciate Ligament Reconstruction
Arthroscopy. 2008 Jun;24(6):625-36.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
35 patients undergoing allograft reconstruction of the anterior cruciate ligament were randomized to arthroscopic irrigation using either OMS103HP or a vehicle solution, assessing OMS103HP's effect on early postoperative function. At 30 day follow up, OMS103HP provided significantly improved postoperative knee motion, quadriceps and hamstring muscle strength, knee function and earlier return to wo...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.